Vitamin and mineral needs during the oral contraceptive therapy: a systematic review

Giulia Dante, Alberto Vaiarelli, Fabio Facchinetti

Abstract


Objectives: There is growing evidence that women using OCs change in serum trace elements and vitamins. Nowadays, in many cases, side effects associated with low levels of micronutrients are not considered during oral contraceptives (OCs) therapy. This review aims at checking the present literature in order to verify the evidences. Our purpose is to underline this aspect contributing to improve the therapeutic approach with OCs.

Methods: Systematic literature search was performed in electronic databases, covering the period from January 1967 to January 2012.

Results: Ninety-five articles were located; a cross sectional randomized and three RCTs studies were considered eligible.

Conclusions: A decrease in the serum concentrations of zinc, selenium, phosphorus and magnesium have been reported in OC users. Such reductions were proportional to the duration of contraceptive use. These reductions may imply a reduction in the probability of having a pregnancy and/or an increase of serious illness for the unborn. In this regard, a supplementation with the above compounds could be useful in OC users, namely for reducing side effects.


Keywords


Oral contraceptive pill, Nutritional requirements, Vitamins deficiency, Micronutrients deficiency, Serum trace elements

Full Text:

PDF

References


Theuer RC. Effect of Oral Contraceptive Agents on Vitamin and Mineral Needs: A Review. J Reprod Med. 1972;8:13-9.

Berg G, Kohlmeier L, Brenner H. Effect of Oral Contraceptive Progestins on Serum Copper Concentration. Eur J Clin Nutr. 1998;52:711-5.

Ghayour-Mobarhan M, Taylor A, New SA, Lamb DJ, Ferns GA. Determinants of Serum Copper, Zinc and Selenium in Healthy Subjects. Ann Clin Biochem. 2005;42:364-75.

Tamura T, Picciano MF. Folate and Human Reproduction. Am J Clin Nutr 2006;83: 993-1016.

Prevention of Neural Tube Defects: Results of the Medical Research Council Vitamin Study. Mrc Vitamin Study Research Group. Lancet. 1991;338:131-7.

Shojania AM, Hornady G, Barnes PH. Oral contraceptives and serum-folate level. Lancet. 1968;1:1376-7.

Prasad AS, Oberleas D, Moghissi KS, Stryker JC, Lei KY. Effect of Oral Contraceptive Agents on Nutrients: Ii. Vitamins. Am J Clin Nutr. 1975;28:385-91.

Wilson SM, Bivins BN, Russell KA, Bailey LB. Oral Contraceptive Use: Impact on Folate, Vitamin B(6), and Vitamin B(1)(2) Status. Nutr Rev. 2011;69:572-83.

Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the Quality of Reports of Meta-Analyses of Randomised Controlled Trials: The Quorom Statement. Quality of Reporting of Meta-Analyses. Lancet. 1999;354:1896-900.

Basnayake S, de Silva SV, Miller PC, Rogers S. A Trial of Daily Vitamin Supplementation as a Means of Reducing Oral Contraceptive Side Effects and Discontinuation in Sri Lanka. Contraception. 1983;27:465-72.

Akinloye O, Adebayo TO, Oguntibeju OO, Oparinde DP, Ogunyemi EO. Effects of Contraceptives on Serum Trace Elements, Calcium and Phosphorus Levels. West Indian Med. J 2011;60:308-15.

Bart S, Sr., Marr J, Diefenbach K, Trummer D, Sampson-Landers C. Folate Status and Homocysteine Levels During a 24-Week Oral Administration of a Folate-Containing Oral Contraceptive: A Randomized, Double-Blind, Active-Controlled, Parallel-Group, Us-Based Multicenter Study. Contraception. 2012;85:42-50.

Villegas-Salas E, Ponce de Leon R, Juarez-Perez MA, Grubb GS. Effect of Vitamin B6 on the Side Effects of a Low-Dose Combined Oral Contraceptive. Contraception. 1997;55: 245-8.

Daly LE, Kirke PN, Molloy A, Weir DG, Scott JM. Folate Levels and Neural Tube Defects. Implications for Prevention. JAMA. 1995;274:1698-702.

Botto LD, Moore CA, Khoury MJ, Erickson JD. Neural-Tube Defects. N Engl J Med. 1999;341:1509-19.

Northrup H, Volcik KA. Spina Bifida and Other Neural Tube Defects. Curr Probl Pediatr. 2000;30:313-32.

Holmes RP. Megaloblastic Anemia Precipitated by the Use of Oral Contraceptive. A Case Report. N C Med J. 1970;31:17-8.

Paton A. Oral Contraceptives and Folate Deficiency. Lancet. 1969;1:418.

Smith JL, Goldsmith GA, Lawrence JD. Effects of Oral Contraceptive Steroids on Vitamin and Lipid Levels in Serum. Am J Clin Nutr. 1975;28:371-6.

Mooij PN, Thomas CM, Doesburg WH, Eskes TK. Multivitamin Supplementation in Oral Contraceptive Users. Contraception. 1991;44:277-88.

Prasad AS, Lei KY, Moghissi KS, Stryker JC, Oberleas D. Effect of Oral Contraceptives on Nutrients. Iii. Vitamins B6, B12, and Folic Acid. Am J Obstet Gynecol. 1976;125:1063-9.

Davis RE, Smith BK. Pyridoxal, Vitamin B12 and Folate Metabolism in Women Taking Oral Contraceptive Agents. S Afr Med J. 1974;48:1937-40.

Stephens ME, Craft J, Peters TJ, Hoffbrand AV. Oral Contraceptives and Folate Metabolism. Clin Sci. 1972;42:405-14.

Da Costa M, Rothenberg SP. Appearance of a Folate Binder in Leukocytes and Serum of Women Who Are Pregnant or Taking Oral Contraceptives. J Lab Clin Med. 1974;83:207-14.

Corrocher R, Abramson RG, King VF, Schreiber C, Dikman S, Waxman S. Differential binding of folates by rat renal cortex brush border and basolateral membrane preparations. Proc Soc Exp Biol Med. 1985;178:73-84.

Maxwell JD, Hunter J, Stewart DA, Ardeman S, Williams R. Folate Deficiency after Anticonvulsant Drugs: An Effect of Hepatic Enzyme Induction? Br Med J. 1972;1:297-9.

Areekul S, Panatampon P, Doungbarn J, Yamarat P, Vongyuthithum M. Serum Vitamin B12, Serum and Red Cell Folates, Vitamin B12 and Folic Acid Binding Proteins in Women Taking Oral Contraceptives. Southeast Asian J Trop Med Public Health. 1977;8:480-5.

Venn BJ, Green TJ, Moser R, Mann JI. Comparison of the Effect of Low-Dose Supplementation with L-5-Methyltetrahydrofolate or Folic Acid on Plasma Homocysteine: A Randomized Placebo-Controlled Study. Am J Clin Nutr. 2003;77:658-62.

Bol KA, Collins JS, Kirby RS; National Birth Defects Prevention Network. Survival of infants with neural tube defects in the presence of folic acid fortification. Pediatrics. 2006;117:803-13.

Pentieva K, McNulty H, Reichert R, Ward M, Strain JJ, McKillop DJ, et al. The Short-Term Bioavailabilities of [6s]-5-Methyltetrahydrofolate and Folic Acid Are Equivalent in Men. J Nutr. 2004;134:580-5.

Snyderman SE, Holt LE, Jr., Carretero R, Jacobs K. Pyridoxine Deficiency in the Human Infant. J Clin Nutr. 1953;1:200-7.

Sahakian V, Rouse D, Sipes S, Rose N, Niebyl J. Vitamin B6 Is Effective Therapy for Nausea and Vomiting of Pregnancy: A Randomized, Double-Blind Placebo-Controlled Study. Obstet Gynecol. 1991;78:33-6.

Kleijnen J, Ter Riet G, Knipschild P. Vitamin B6 in the Treatment of the Premenstrual Syndrome--a Review. Br J Obstet Gynaecol. 1990;97:847-52.

Aly HE, Donald EA, Simpson MH. Oral Contraceptives and Vitamin B6 Metabolism. Am J Clin Nutr. 1971;24:297-303.

Price JM, Thornton MJ, Mueller LM. Tryptophan Metabolism in Women Using Steroid Hormones for Ovulation Control. Am J Clin Nutr. 1967;20:452-6.

Luhby A, Reyniak J, Brin M, Sambour M, Brin H. Abnormal Vitamin B6 Metabolism in Menopausal Women Given Estrogenic Steroids and Its Correction by Pyridoxine. American Journal of Clinical Nutrition. 1973;26:468-69.

Bulbrook RD, Herian M, Tong D, Hayward JL, Swain MC, Wang DY. Effect of Steroidal Contraceptives on Levels of Plasma Androgen Sulphates and Cortisol. Lancet. 1973;1:628-31.

Luhby AL, Brin M, Gordon M, Davis P, Murphy M, Spiegel H. Vitamin B 6 Metabolism in Users of Oral Contraceptive Agents. I. Abnormal Urinary Xanthurenic Acid Excretion and Its Correction by Pyridoxine. Am J Clin Nutr. 1971;24:684-93.

Dror DK, Allen LH. Effect of Vitamin B12 Deficiency on Neurodevelopment in Infants: Current Knowledge and Possible Mechanisms. Nutr Rev. 2008;66:250-5.

Adams MJ Jr, Khoury MJ, Scanlon KS, Stevenson RE, Knight GJ, Haddow JE et al. Elevated Midtrimester Serum Methylmalonic Acid Levels as a Risk Factor for Neural Tube Defects. Teratology. 1995;51:311-7.

Pietarinen GJ, Leichter J, Pratt RF. Dietary Folate Intake and Concentration of Folate in Serum and Erythrocytes in Women Using Oral Contraceptives. Am J Clin Nutr. 1977;30:375-80.

Riedel B, Bjorke Monsen AL, Ueland PM, Schneede J. Effects of Oral Contraceptives and Hormone Replacement Therapy on Markers of Cobalamin Status. Clin Chem. 2005;51:778-81.

Shojania AM, Wylie B. The Effect of Oral Contraceptives on Vitamin B12 Metabolism. Am J Obstet Gynecol. 1979;135:129-34.

Gardyn J, Mittelman M, Zlotnik J, Sela BA, Cohen AM. Oral Contraceptives Can Cause Falsely Low Vitamin B(12) Levels. Acta Haematol. 2000;104:22-4.

Bush AI. The Metallobiology of Alzheimer's Disease. Trends Neurosci. 2003;26: 207-14.

Schrauzer GN. Selenium and Cancer: A Review. Bioinorg Chem. 1976;5:275-81.

Crews MG, Taper LJ, Ritchey SJ. Effects of Oral Contraceptive Agents on Copper and Zinc Balance in Young Women. Am J Clin Nutr. 1980;33:1940-5.

Hameed A, Majeed T, Rauf S, Ashraf M, Jalil MA, Nasrullah M et al. Effect of Oral and Injectable Contraceptives on Serum Calcium, Magnesium and Phosphorus in Women. J Ayub Med Coll Abbottabad. 2001;13:24-5.

Blum M, Kitai E, Ariel Y, Schnierer M, Bograd H. Oral Contraceptive Lowers Serum Magnesium. Harefuah. 1991;121:363-4.

Ynsa MD, Ager FJ, Millan JC, Gomez-Zubelbia MA, Pinheiro T. Effect of Hormone Replacement Therapy on the Elemental Contents of Uterine Tissue. Biol Trace Elem Res. 2004;101:37-46.

Greig AJ, Palmer MA, Chepulis LM. Hormonal Contraceptive Practices in Young Australian Women (=25 Years) and Their Possible Impact on Menstrual Frequency and Iron Requirements. Sex Reprod Healthc. 2010;1:99-103.